v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Deficit - USD ($)
$ in Thousands
Series A-1
preferred stock
Series B
preferred stock
Common stock
Series A-1 preferred stock to be issued
Common stock to be issued
Common stock held in escrow
Additional paid-in capital
Accumulated other comprehensive income loss
Accumulated deficit
Total
Balance at Dec. 31, 2024 $ 12 [1] $ 14 [2] $ 12 $ 1 [2] $ 2 [2] $ 958,177 $ (548) $ (1,203,637) $ (245,967)
Balance (in Shares) at Dec. 31, 2024 11,801,804 30,851 13,814,382 [2] 11,801,804 1,502,271 [2] 2,402,243 [2]        
Settlement of payables with common stock held in escrow [1],[2] [2] [1],[2]
Settlement of payables with common stock held in escrow (in Shares) 204,396 [2] [2] (204,396) [2]        
Issuance of common stock for repayment of borrowings, related party [1],[2] [2] [2] 554 554
Issuance of common stock for repayment of borrowings, related party (in Shares) 15,500 [2] [2] [2]        
Stock-based compensation to a consultant [1],[2] [1],[2] [2] 3,679 3,679
Stock-based compensation to a consultant (in Shares) 357,625 [2] (322,750) [2] [2]        
Stock-based compensation to directors, officers, and employees $ 1 [2] [2] [2] 43,890 43,891
Stock-based compensation to directors, officers, and employees (in Shares) 471,580 [2] [2] [2]        
Settlement of Series A-1 preferred stock to be issued in related to merger transaction $ 1 [2] $ 12 [2] [2] 11
Settlement of Series A-1 preferred stock to be issued in related to merger transaction (in Shares) 1,180,733 [2] 11,801,804 [2] [2]        
Foreign currency translation adjustment [2] [2] [2] 808 808
Net loss for the period [2] [2] [2] (85,257) (85,257)
Balance at Jun. 30, 2025 $ 12 [1] $ 16 [2] $ 1 [2] $ 2 [2] 1,006,311 260 (1,288,894) (282,292)
Balance (in Shares) at Jun. 30, 2025 11,801,804 30,851 16,044,216 [2] 1,179,521 [2] 2,197,847 [2]        
Balance at Dec. 31, 2025 $ 12 [1] $ 17 $ 1 $ 2 1,050,531 (500) (1,378,179) (328,116)
Balance (in Shares) at Dec. 31, 2025 11,801,804 30,851 17,528,852 1,179,521 2,197,847        
Stock-based compensation to a consultant $ 1 [1] (968) (967)
Stock-based compensation to a consultant (in Shares) 595,070 (504,297)        
Stock-based compensation to directors, officers, and employees [1] 15,583 15,583
Stock-based compensation to directors, officers, and employees (in Shares) 167,382        
Redemption of Series B shares [1]
Redemption of Series B shares (in Shares) (30,851)        
Fractional shares cancelled pursuant to reverse stock split
Fractional shares cancelled pursuant to reverse stock split (in Shares) (1,742)        
Foreign currency translation adjustment 708 708
Net loss for the period (60,581) (60,581)
Balance at Jun. 30, 2026 $ 12 $ 18 $ 1 $ 2 $ 1,065,146 $ 208 $ (1,438,760) $ (373,373)
Balance (in Shares) at Jun. 30, 2026 11,801,804 18,289,562 675,224 2,197,847        
[1] Less than $1,000
[2] Giving retroactive effect to the 1-for-10 reverse stock split effective June 22, 2026 (see Note 12).